Kolmar Korea- Gwanjeong Factory on FDA Import Alert List
Kolmar Korea said it would sell its pharmaceutical business unit and Kolmar Pharma, a subsidiary of the company, to IMM Private Equity, one of the nation’s largest private equity funds.
Kolmar Korea Co. Ltd. on FDA Import Alert List
The US Food and Drug Administration (FDA) on Tuesday released warning letters sent to drugmakers in Australia and Korea over good manufacturing practice (GMP) violations and warned the operators of more than 50 websites for illegally selling unapproved opioids.
Kolmar Korea Receives FDA Warning Letter